Paediatric chronic kidney disease

Area of Science:

• Pediatric Nephrology
• Chronic Kidney Disease (CKD) Management
• Renal Replacement Therapy

Background:

• Chronic kidney disease (CKD) in children shares progression risks with adults, potentially leading to end-stage renal failure.
• Disease progression is influenced by modifiable factors, necessitating tailored management strategies based on resource availability.
• CKD staging, based on cause, glomerular filtration rate, and proteinuria, is crucial for determining prognosis and treatment pathways.

Purpose of the Study:

• To provide comprehensive information on the diagnosis and treatment of pediatric chronic kidney disease (CKD).
• To emphasize the importance of early identification and management of modifiable risk factors in children with CKD.
• To highlight the role of renoprotective treatments in preventing complications and delaying renal replacement therapy.

Main Methods:

• Review of current guidelines and established staging criteria for pediatric CKD.
• Focus on identifying and categorizing modifiable factors influencing CKD progression.
• Emphasis on diagnostic approaches and therapeutic interventions for hypertension and proteinuria.

Main Results:

• CKD staging provides a framework for assessing disease severity and guiding management.
• Hypertension and proteinuria are identified as key modifiable factors significantly impacting CKD progression.
• Early intervention targeting these factors can alter the disease trajectory.

Conclusions:

• Early diagnosis and staged management are essential for optimizing outcomes in pediatric CKD.
• Aggressive treatment of hypertension and proteinuria can significantly reduce the burden of CKD in children.
• Effective management strategies can delay or prevent the need for renal replacement therapy, improving long-term patient prognosis.